{"nct_id":"NCT05735483","title":"A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis","status":"ENROLLING_BY_INVITATION","status_verified_date":"2025-09","start_date":"2023-03-09","start_date_type":"ACTUAL","primary_completion_date":"2027-12","primary_completion_date_type":"ESTIMATED","completion_date":"2029-04","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}